HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Syrbe Selected Research

Secondary Prevention

7/2001Individual dosing of ASA prophylaxis by controlling platelet aggregation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Syrbe Research Topics

Disease

2Hemophilia A (Haemophilia)
01/2012 - 01/2008
1Body Weight (Weight, Body)
01/2012
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
06/2008
1Multiple Sclerosis
06/2008
1Type 3 von Willebrand Disease
01/2008
1Cardiovascular Diseases (Cardiovascular Disease)
07/2001

Drug/Important Bio-Agent (IBA)

1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
01/2012
1Nitrofurantoin (Macrodantin)FDA LinkGeneric
06/2008
1Pharmaceutical PreparationsIBA
06/2008
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2008
1Factor VIII (Coagulation Factor VIII)IBA
01/2008
1A-factor (Streptomyces)IBA
01/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2001
1Arachidonic Acid (Vitamin F)IBA
07/2001

Therapy/Procedure

1Secondary Prevention
07/2001